TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Allergan, Celgene Offer Solid Biotech Value
INVESTING

Allergan, Celgene Offer Solid Biotech Value

  • By Bret Jensen
  • Jul 7, 2017 4:30 PM EDT
Medtronic Earnings Rebound in Third Quarter, Shares Climb
STOCKS

Medtronic earnings rebound in third quarter, shares climb

  • By Alicia McElhaney
  • Feb 21, 2017 10:58 AM EST
Deals of the Week: Valentine Couplings and Breakups
MERGERS AND ACQUISITIONS

Deals of the week: couplings and breakups on valentine's week

  • By Chris Nolter
  • Feb 17, 2017 4:22 PM EST
5 Things You Must Know Before the Market Opens Wednesday
FUTURES

Wall Street smashes record for fourth day in a row after rocky session

  • By Keris Alison Lahiff
  • Feb 14, 2017 4:06 PM EST
Stocks Close Higher Even as Fed Ponders Accelerated Pace of Rate Hikes
FUTURES

Stocks find upward momentum again as chances of a rate hike rise

  • By Keris Alison Lahiff
  • Feb 14, 2017 1:46 PM EST
Stocks Trade Flat as Trump Pledges $54B Bump in Defense Spending
FUTURES

Stocks mixed as Fed's Yellen talks rates on Capitol Hill

  • By Keris Alison Lahiff
  • Feb 14, 2017 11:30 AM EST
Valeant Shows Signs Its Turnaround Efforts Are Bearing Fruit; Jim Cramer Weighs In
STOCKS

Valeant, Pershing Square will split legal costs on Allergan lawsuit

  • By Alicia McElhaney
  • Feb 14, 2017 9:24 AM EST
Chesapeake Energy, Comcast, Citigroup: 'Mad Money' Lightning Round
JIM CRAMER

Chesapeake Energy, Priceline, Schlumberger, ZELTIQ : 'Mad Money' Lightning Round

  • By Scott Rutt
  • Feb 14, 2017 6:14 AM EST
Why These Market Gains Are More Powerful Than Trump: Cramer's 'Mad Money' Recap (Monday 2/13/17)
JIM CRAMER

Why These Market Gains Are More Powerful Than Trump: Cramer's 'Mad Money' Recap

  • By Scott Rutt
  • Feb 14, 2017 6:08 AM EST
5 Things You Must Know Before the Market Opens Wednesday
FUTURES

Records for Wall Street for day three as good vibes linger

  • By Keris Alison Lahiff
  • Feb 13, 2017 4:06 PM EST
Stocks Extend Gains, on Track to Close at Records for Third Day in Row
FUTURES

Stocks on track to close at records for third day in row

  • By Keris Alison Lahiff
  • Feb 13, 2017 2:35 PM EST
Market Recon: Markets Are Pricing in a Growth-Inspired Goodness
STOCKS

Most active stocks and how to trade them: BofA, Vale, Zeltiq, Teva and more

  • By Jonas Elmerraji
  • Feb 13, 2017 1:26 PM EST
Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics
VIDEO

Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics

  • By Scott Gamm
  • Feb 13, 2017 12:12 PM EST
Sears, Kmart Drop Trump Lines; Stocks Trade at Records: Midday Report
VIDEO

Sears, Kmart Drop Trump Lines; Stocks Trade at Records: Midday Report

  • By Keris Alison Lahiff
  • Feb 13, 2017 12:10 PM EST
Allergan 'Very Attractive' After Buybacks, Dividend Increase -Cramer Says
MERGERS AND ACQUISITIONS

Allergan shares rise on $2.5B deal for body-sculptor Zeltiq

  • By Sarah Pringle
  • Feb 13, 2017 11:11 AM EST
Stocks Inch Higher in Cautious Trading Ahead of Trump's Budget, Tax Plans
FUTURES

Stocks trade above record closes, Apple nears all-time high

  • By Keris Alison Lahiff
  • Feb 13, 2017 11:00 AM EST
Top 7 Financial Stocks to Own for 2017
FUTURES

Stock futures take baby steps in effort to extends Friday's record run

  • By Keris Alison Lahiff
  • Feb 13, 2017 9:00 AM EST
3 Top Off-the-Radar Consumer Stocks for 2017
VIDEO

3 Top Off-the-Radar Consumer Stocks for 2017

  • By Gregg Greenberg
  • Dec 8, 2016 4:41 PM EST
From the Absurd to the Ridiculous: When Fundamentals Don't Matter
MARKETS

Zeltiq Aesthetics (ZLTQ) Stock Jumps on Q2 Revenue Beat, Higher Forecast

  • By Kaya Yurieff
  • Aug 9, 2016 12:57 PM EDT
Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

ZELTIQ Aesthetics (ZLTQ) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Aug 9, 2016 10:00 AM EDT
Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal
OPINION

These 4 medical technology stocks really stand out

  • By Gregg Greenberg
  • Aug 3, 2016 11:40 AM EDT
4 Standout Medical Technology Stocks
VIDEO

4 Standout Medical Technology Stocks

  • By Gregg Greenberg
  • Aug 3, 2016 11:10 AM EDT
Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

ZELTIQ Aesthetics (ZLTQ) Is Today's Strong On High Volume Stock

  • By TheStreet Wire
  • Jul 13, 2016 10:13 AM EDT
Nasdaq Touches Record as Broad Gains Overshadow Healthcare Stock Rout
OPINION

Why Zeltiq Aesthetics is the one medical device stock to buy now

  • By Chiradeep BasuMallick
  • Jun 7, 2016 1:03 PM EDT
Inevitable Automation of the Fund Management Industry Is Upon Us
MARKETS

Zeltiq Aesthetics (ZLTQ) Stock Tumbles After Q1 Results

  • By Kaya Yurieff
  • May 11, 2016 1:54 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.